LMPM
MCID: LYM094
MIFTS: 31

Lymphedema, Primary, with Myelodysplasia (LMPM)

Categories: Blood diseases, Cancer diseases, Cardiovascular diseases, Ear diseases, Fetal diseases, Genetic diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Lymphedema, Primary, with Myelodysplasia

MalaCards integrated aliases for Lymphedema, Primary, with Myelodysplasia:

Name: Lymphedema, Primary, with Myelodysplasia 58 76 30 6 41
Emberger Syndrome 58 60 76 13 74
Deafness-Lymphedema-Leukemia Syndrome 60
Lmpm 76

Characteristics:

Orphanet epidemiological data:

60
deafness-lymphedema-leukemia syndrome
Inheritance: Autosomal dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood;

OMIM:

58
Inheritance:
autosomal dominant


HPO:

33
lymphedema, primary, with myelodysplasia:
Inheritance autosomal dominant inheritance


Classifications:



Summaries for Lymphedema, Primary, with Myelodysplasia

UniProtKB/Swiss-Prot : 76 Lymphedema, primary, with myelodysplasia: A chronic disabling condition characterized by swelling of the extremities due to altered lymphatic flow, associated with myelodysplasia. Patients with lymphedema suffer from recurrent local infections, and physical impairment.

MalaCards based summary : Lymphedema, Primary, with Myelodysplasia, also known as emberger syndrome, is related to immunodeficiency 21 and deafness-lymphedema-leukemia syndrome. An important gene associated with Lymphedema, Primary, with Myelodysplasia is GATA2 (GATA Binding Protein 2). Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are epicanthus and webbed neck

Description from OMIM: 614038

Related Diseases for Lymphedema, Primary, with Myelodysplasia

Diseases related to Lymphedema, Primary, with Myelodysplasia via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 immunodeficiency 21 11.5
2 deafness-lymphedema-leukemia syndrome 11.4
3 lymphedema 10.2
4 benign mesothelioma 10.1
5 malignant pleural mesothelioma 10.1
6 leukemia, acute myeloid 10.0
7 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
8 hematopoietic stem cell transplantation 10.0
9 leukemia 10.0
10 myeloid leukemia 10.0

Graphical network of the top 20 diseases related to Lymphedema, Primary, with Myelodysplasia:



Diseases related to Lymphedema, Primary, with Myelodysplasia

Symptoms & Phenotypes for Lymphedema, Primary, with Myelodysplasia

Human phenotypes related to Lymphedema, Primary, with Myelodysplasia:

33 60 (show all 35)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 epicanthus 33 occasional (7.5%) HP:0000286
2 webbed neck 33 occasional (7.5%) HP:0000465
3 hypotelorism 33 occasional (7.5%) HP:0000601
4 tapered finger 33 occasional (7.5%) HP:0001182
5 lymphedema 60 33 Very frequent (99-80%) HP:0001004
6 nausea and vomiting 60 Frequent (79-30%)
7 neurological speech impairment 60 Very frequent (99-80%)
8 chronic otitis media 60 Frequent (79-30%)
9 splenomegaly 60 Frequent (79-30%)
10 recurrent respiratory infections 60 Frequent (79-30%)
11 hepatomegaly 60 Frequent (79-30%)
12 sensorineural hearing impairment 60 Very frequent (99-80%)
13 fever 60 Frequent (79-30%)
14 fatigue 60 Very frequent (99-80%)
15 pancytopenia 33 HP:0001876
16 bone marrow hypocellularity 60 Very frequent (99-80%)
17 hypercoagulability 60 Frequent (79-30%)
18 pallor 60 Frequent (79-30%)
19 myelodysplasia 33 HP:0002863
20 weight loss 60 Frequent (79-30%)
21 thrombocytopenia 60 Very frequent (99-80%)
22 migraine 60 Frequent (79-30%)
23 vertigo 60 Frequent (79-30%)
24 visual loss 60 Frequent (79-30%)
25 respiratory failure 60 Very frequent (99-80%)
26 leukocytosis 60 Occasional (29-5%)
27 cellulitis 33 HP:0100658
28 bruising susceptibility 60 Frequent (79-30%)
29 intracranial hemorrhage 60 Frequent (79-30%)
30 acute leukemia 60 Very frequent (99-80%)
31 prolonged bleeding time 60 Very frequent (99-80%)
32 lymphadenopathy 60 Occasional (29-5%)
33 abnormality of the optic nerve 60 Frequent (79-30%)
34 myeloproliferative disorder 60 Occasional (29-5%)
35 abnormal neutrophil cell number 60 Very frequent (99-80%)

Symptoms via clinical synopsis from OMIM:

58
Hematology:
pancytopenia
myelodysplasia
bone marrow monosomy 7

Genitourinary External Genitalia Female:
lymphedema

Head And Neck Eyes:
hypotelorism (in some patients)
epicanthic folds (in some patients)

Head And Neck Ears:
deafness, congenital sensorineural, profound (in some patients)

Skin Nails Hair Skin:
cellulitis, recurrent
warts, generalized (in some patients)

Genitourinary External Genitalia Male:
lymphedema

Muscle Soft Tissue:
lymphedema, lower extremities

Head And Neck Neck:
webbed neck (in some patients)

Skeletal Hands:
long, tapering fingers (in some patients)

Neoplasia:
leukemia, acute myeloid

Clinical features from OMIM:

614038

Drugs & Therapeutics for Lymphedema, Primary, with Myelodysplasia

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Familial Investigations of Childhood Cancer Predisposition Recruiting NCT03050268

Search NIH Clinical Center for Lymphedema, Primary, with Myelodysplasia

Genetic Tests for Lymphedema, Primary, with Myelodysplasia

Genetic tests related to Lymphedema, Primary, with Myelodysplasia:

# Genetic test Affiliating Genes
1 Lymphedema, Primary, with Myelodysplasia 30 GATA2

Anatomical Context for Lymphedema, Primary, with Myelodysplasia

MalaCards organs/tissues related to Lymphedema, Primary, with Myelodysplasia:

42
Myeloid, Bone, Bone Marrow, Skin, Neutrophil

Publications for Lymphedema, Primary, with Myelodysplasia

Articles related to Lymphedema, Primary, with Myelodysplasia:

# Title Authors Year
1
Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation. ( 29189513 )
2018
2
Emberger syndrome: A rare association with hearing loss. ( 29605372 )
2018
3
Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome. ( 28234738 )
2017
4
GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome. ( 28271814 )
2017
5
First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation. ( 26767875 )
2016
6
A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene. ( 29906059 )
2016
7
Errata: A Rare Case of Emberger Syndrome Caused by a De Novo Mutation in the GATA2 Gene. ( 29906369 )
2016
8
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). ( 21892158 )
2011
9
Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. ( 20803646 )
2010

Variations for Lymphedema, Primary, with Myelodysplasia

UniProtKB/Swiss-Prot genetic disease variations for Lymphedema, Primary, with Myelodysplasia:

76
# Symbol AA change Variation ID SNP ID
1 GATA2 p.Arg361Pro VAR_066644
2 GATA2 p.Cys373Arg VAR_066645 rs387906633

ClinVar genetic disease variations for Lymphedema, Primary, with Myelodysplasia:

6 (show top 50) (show all 422)
# Gene Variation Type Significance SNP ID Assembly Location
1 GATA2 NM_032638.4(GATA2): c.1061C> T (p.Thr354Met) single nucleotide variant Pathogenic rs387906631 GRCh37 Chromosome 3, 128200744: 128200744
2 GATA2 NM_032638.4(GATA2): c.1061C> T (p.Thr354Met) single nucleotide variant Pathogenic rs387906631 GRCh38 Chromosome 3, 128481901: 128481901
3 GATA2 GATA2, 2-BP INS, 310CC insertion Pathogenic
4 GATA2 GATA2, 1-BP INS, 230C insertion Pathogenic
5 GATA2 NM_001145661.1(GATA2): c.1009C> T (p.Arg337Ter) single nucleotide variant Pathogenic rs387906632 GRCh37 Chromosome 3, 128202711: 128202711
6 GATA2 NM_001145661.1(GATA2): c.1009C> T (p.Arg337Ter) single nucleotide variant Pathogenic rs387906632 GRCh38 Chromosome 3, 128483868: 128483868
7 GATA2 NM_001145661.1(GATA2): c.1117T> C (p.Cys373Arg) single nucleotide variant Pathogenic rs387906633 GRCh37 Chromosome 3, 128200688: 128200688
8 GATA2 NM_001145661.1(GATA2): c.1117T> C (p.Cys373Arg) single nucleotide variant Pathogenic rs387906633 GRCh38 Chromosome 3, 128481845: 128481845
9 GATA2 NM_001145661.1(GATA2): c.1082G> T (p.Arg361Leu) single nucleotide variant Pathogenic rs387906634 GRCh37 Chromosome 3, 128200723: 128200723
10 GATA2 NM_001145661.1(GATA2): c.1082G> T (p.Arg361Leu) single nucleotide variant Pathogenic rs387906634 GRCh38 Chromosome 3, 128481880: 128481880
11 GATA2 NM_032638.4(GATA2): c.371C> A (p.Thr124Lys) single nucleotide variant Uncertain significance rs569301892 GRCh37 Chromosome 3, 128205070: 128205070
12 GATA2 NM_032638.4(GATA2): c.371C> A (p.Thr124Lys) single nucleotide variant Uncertain significance rs569301892 GRCh38 Chromosome 3, 128486227: 128486227
13 GATA2 NM_032638.4(GATA2): c.481C> G (p.Pro161Ala) single nucleotide variant Benign/Likely benign rs34799090 GRCh37 Chromosome 3, 128204960: 128204960
14 GATA2 NM_032638.4(GATA2): c.481C> G (p.Pro161Ala) single nucleotide variant Benign/Likely benign rs34799090 GRCh38 Chromosome 3, 128486117: 128486117
15 GATA2 NM_001145661.1(GATA2): c.748C> G (p.Pro250Ala) single nucleotide variant Benign/Likely benign rs78245253 GRCh37 Chromosome 3, 128204693: 128204693
16 GATA2 NM_001145661.1(GATA2): c.748C> G (p.Pro250Ala) single nucleotide variant Benign/Likely benign rs78245253 GRCh38 Chromosome 3, 128485850: 128485850
17 GATA2 NM_001145661.1(GATA2): c.490G> A (p.Ala164Thr) single nucleotide variant Benign/Likely benign rs2335052 GRCh37 Chromosome 3, 128204951: 128204951
18 GATA2 NM_001145661.1(GATA2): c.490G> A (p.Ala164Thr) single nucleotide variant Benign/Likely benign rs2335052 GRCh38 Chromosome 3, 128486108: 128486108
19 GATA2 NM_032638.4(GATA2): c.787G> A (p.Gly263Arg) single nucleotide variant Uncertain significance rs587778378 GRCh37 Chromosome 3, 128204654: 128204654
20 GATA2 NM_032638.4(GATA2): c.787G> A (p.Gly263Arg) single nucleotide variant Uncertain significance rs587778378 GRCh38 Chromosome 3, 128485811: 128485811
21 GATA2 NM_032638.4(GATA2): c.1122_1125dupCCTC (p.Tyr376Profs) duplication Pathogenic rs863224874 GRCh37 Chromosome 3, 128200680: 128200683
22 GATA2 NM_032638.4(GATA2): c.1122_1125dupCCTC (p.Tyr376Profs) duplication Pathogenic rs863224874 GRCh38 Chromosome 3, 128481837: 128481840
23 GATA2 NM_032638.4(GATA2): c.1113C> A (p.Asn371Lys) single nucleotide variant Likely pathogenic rs376003468 GRCh38 Chromosome 3, 128481849: 128481849
24 GATA2 NM_032638.4(GATA2): c.1113C> A (p.Asn371Lys) single nucleotide variant Likely pathogenic rs376003468 GRCh37 Chromosome 3, 128200692: 128200692
25 GATA2 NM_032638.4(GATA2): c.1021_1024dupGCCG (p.Ala342Glyfs) duplication Likely pathogenic rs869320770 GRCh38 Chromosome 3, 128481938: 128481941
26 GATA2 NM_032638.4(GATA2): c.1021_1024dupGCCG (p.Ala342Glyfs) duplication Likely pathogenic rs869320770 GRCh37 Chromosome 3, 128200781: 128200784
27 GATA2 NM_032638.4(GATA2): c.*183C> T single nucleotide variant Benign/Likely benign rs45598538 GRCh37 Chromosome 3, 128199679: 128199679
28 GATA2 NM_032638.4(GATA2): c.*183C> T single nucleotide variant Benign/Likely benign rs45598538 GRCh38 Chromosome 3, 128480836: 128480836
29 GATA2 NM_032638.4(GATA2): c.1410C> T (p.Pro470=) single nucleotide variant Likely benign rs878855169 GRCh37 Chromosome 3, 128199895: 128199895
30 GATA2 NM_032638.4(GATA2): c.1410C> T (p.Pro470=) single nucleotide variant Likely benign rs878855169 GRCh38 Chromosome 3, 128481052: 128481052
31 GATA2 NM_032638.4(GATA2): c.1359G> A (p.Leu453=) single nucleotide variant Likely benign rs878855168 GRCh37 Chromosome 3, 128199946: 128199946
32 GATA2 NM_032638.4(GATA2): c.1359G> A (p.Leu453=) single nucleotide variant Likely benign rs878855168 GRCh38 Chromosome 3, 128481103: 128481103
33 GATA2 NM_032638.4(GATA2): c.1144-6C> T single nucleotide variant Likely benign rs878855167 GRCh37 Chromosome 3, 128200167: 128200167
34 GATA2 NM_032638.4(GATA2): c.1144-6C> T single nucleotide variant Likely benign rs878855167 GRCh38 Chromosome 3, 128481324: 128481324
35 GATA2 NM_032638.4(GATA2): c.1035C> G (p.Ala345=) single nucleotide variant Likely benign rs371599112 GRCh37 Chromosome 3, 128200770: 128200770
36 GATA2 NM_032638.4(GATA2): c.1035C> G (p.Ala345=) single nucleotide variant Likely benign rs371599112 GRCh38 Chromosome 3, 128481927: 128481927
37 GATA2 NM_032638.4(GATA2): c.1017+8C> T single nucleotide variant Likely benign rs200848213 GRCh37 Chromosome 3, 128202695: 128202695
38 GATA2 NM_032638.4(GATA2): c.1017+8C> T single nucleotide variant Likely benign rs200848213 GRCh38 Chromosome 3, 128483852: 128483852
39 GATA2 NM_032638.4(GATA2): c.279G> A (p.Pro93=) single nucleotide variant Benign rs142993548 GRCh37 Chromosome 3, 128205162: 128205162
40 GATA2 NM_032638.4(GATA2): c.279G> A (p.Pro93=) single nucleotide variant Benign rs142993548 GRCh38 Chromosome 3, 128486319: 128486319
41 GATA2 NM_032638.4(GATA2): c.182C> T (p.Ala61Val) single nucleotide variant Uncertain significance rs375349195 GRCh38 Chromosome 3, 128486850: 128486850
42 GATA2 NM_032638.4(GATA2): c.182C> T (p.Ala61Val) single nucleotide variant Uncertain significance rs375349195 GRCh37 Chromosome 3, 128205693: 128205693
43 GATA2 NM_032638.4(GATA2): c.142T> A (p.Phe48Ile) single nucleotide variant Uncertain significance rs878855170 GRCh37 Chromosome 3, 128205733: 128205733
44 GATA2 NM_032638.4(GATA2): c.142T> A (p.Phe48Ile) single nucleotide variant Uncertain significance rs878855170 GRCh38 Chromosome 3, 128486890: 128486890
45 GATA2 NM_032638.4(GATA2): c.136G> A (p.Asp46Asn) single nucleotide variant Uncertain significance rs370750401 GRCh37 Chromosome 3, 128205739: 128205739
46 GATA2 NM_032638.4(GATA2): c.136G> A (p.Asp46Asn) single nucleotide variant Uncertain significance rs370750401 GRCh38 Chromosome 3, 128486896: 128486896
47 GATA2 NM_032638.4(GATA2): c.121C> G (p.Pro41Ala) single nucleotide variant Conflicting interpretations of pathogenicity rs143590990 GRCh37 Chromosome 3, 128205754: 128205754
48 GATA2 NM_032638.4(GATA2): c.121C> G (p.Pro41Ala) single nucleotide variant Conflicting interpretations of pathogenicity rs143590990 GRCh38 Chromosome 3, 128486911: 128486911
49 GATA2 NM_001145661.1(GATA2): c.1233G> A (p.Ala411=) single nucleotide variant Benign/Likely benign rs34172218 GRCh37 Chromosome 3, 128200072: 128200072
50 GATA2 NM_001145661.1(GATA2): c.1233G> A (p.Ala411=) single nucleotide variant Benign/Likely benign rs34172218 GRCh38 Chromosome 3, 128481229: 128481229

Expression for Lymphedema, Primary, with Myelodysplasia

Search GEO for disease gene expression data for Lymphedema, Primary, with Myelodysplasia.

Pathways for Lymphedema, Primary, with Myelodysplasia

GO Terms for Lymphedema, Primary, with Myelodysplasia

Sources for Lymphedema, Primary, with Myelodysplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....